Pharma Stocks

What investors should know before buying now

You’re eyeing Astellas Pharma Inc for your portfolio—here’s the clear picture on its oncology focus, global reach, and what drives…

Read More »

What you should know before investing now

Curious if Huadong Medicine Co Ltd offers real value in China’s pharma boom? This deep dive breaks down its business,…

Read More »

Assessing Bayer (XTRA:BAYN) Valuation After Leadership Shift In U.S. Pharmaceuticals

Bayer’s leadership reshuffle in U.S. pharmaceuticals Bayer (XTRA:BAYN) has announced that Nelson Ambrogio will become President of Bayer U.S. Pharmaceuticals…

Read More »

Piramal Pharma Ltd Sees Technical Momentum Shift Amid Mix…

Technical Trend Overview and Price Movement The stock closed at ₹143.90, up from the previous close of ₹141.05, marking a…

Read More »

Why Terns Pharmaceuticals Stock Rocked the Market in March

Key Points All told, the transaction is valued at around $6.7 billion. If all goes well, it’ll close this quarter.…

Read More »

Why this Japanese pharma gem deserves your attention now

In a crowded healthcare market, Hisamitsu Pharmaceutical stands out with its dominance in transdermal patches and global expansion push. You…

Read More »

What investors should know about its steady pharma powerhouse status

As a global leader in innovative medicines, Novartis AG offers stability and growth potential in a volatile pharma sector. Whether…

Read More »

Assessing InnoCare Pharma (SEHK:9969) Valuation After Its 2025 Profit Turnaround

Earnings shift draws fresh attention to InnoCare Pharma InnoCare Pharma (SEHK:9969) has drawn fresh attention after reporting full year 2025…

Read More »

New Halozyme deal signals pipeline push

Vertex Pharmaceuticals just inked a key collaboration with Halozyme on advanced drug delivery tech, potentially boosting its pipeline for serious…

Read More »

IQVIA.ai Launch With Nvidia Puts AI At Core Of Pharma Ties

IQVIA Holdings has launched IQVIA.ai, a unified AI platform built with Nvidia technology for the life sciences sector. The platform…

Read More »